Independently verified quality
3,000+
satisfied researchers
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
Research peptide · EDR
Pinealon 10 mg EDR tripeptide research material. Choose 1, 2 or 3 vials for 10, 20 or 30 mg total content.
Independently verified quality
3,000+
satisfied researchers
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
Research peptide · EDR
Pinealon 10 mg EDR tripeptide research material. Choose 1, 2 or 3 vials for 10, 20 or 30 mg total content.
No reviews yet. Be the first to share your experience.
No reviews yet. Be the first to share your experience.
/ vial
Order today → Delivery Thu, Nov 12 – Fri, Nov 20 to United States
/ vial
Order today → Delivery Thu, Nov 12 – Fri, Nov 20 to United States
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
3,000+ satisfied researchers
Pinealon 10 mg - 1 Vial vial + 2 ml BAC water → concentration:
Per unit (10 IU)
0.50 mg
Research details
Pinealon is a synthetic tripeptide with the amino-acid sequence Glu-Asp-Arg, commonly abbreviated EDR. Its defined sequence makes it a distinct material for experimental peptide research.
This product contains 10 mg of Pinealon per vial. It is supplied as research material for laboratory work and is not presented as a medicine, food, supplement or product for human or animal use.
Pinealon has been studied in experimental models of cellular stress and neuronal function. A published rat study examined prenatal hyperhomocysteinemia, behavioural measurements and the response of cerebellar neurons to oxidative stress. These are preclinical findings from a specific model, rather than evidence of a clinical benefit in people.
The sequence Glu-Asp-Arg distinguishes Pinealon from other short peptides such as Epithalon. Researchers comparing the literature should therefore match the full compound identity and experimental model rather than relying on a shared peptide category.
Each vial contains 10 mg of Pinealon. Select one vial for 10 mg total content, two vials for 20 mg, or three vials for 30 mg.
The 10 mg strength describes every individual vial. The pack choice changes the number of separately supplied vials, not the content of a single vial.
Synthetic tripeptide with the sequence Glu-Asp-Arg (EDR).
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.43% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.
Pinealon is the synthetic EDR tripeptide, with the sequence Glu-Asp-Arg.
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
3,000+ satisfied researchers
Pinealon 10 mg - 1 Vial vial + 2 ml BAC water → concentration:
Per unit (10 IU)
0.50 mg
Research details
Pinealon is a synthetic tripeptide with the amino-acid sequence Glu-Asp-Arg, commonly abbreviated EDR. Its defined sequence makes it a distinct material for experimental peptide research.
This product contains 10 mg of Pinealon per vial. It is supplied as research material for laboratory work and is not presented as a medicine, food, supplement or product for human or animal use.
Pinealon has been studied in experimental models of cellular stress and neuronal function. A published rat study examined prenatal hyperhomocysteinemia, behavioural measurements and the response of cerebellar neurons to oxidative stress. These are preclinical findings from a specific model, rather than evidence of a clinical benefit in people.
The sequence Glu-Asp-Arg distinguishes Pinealon from other short peptides such as Epithalon. Researchers comparing the literature should therefore match the full compound identity and experimental model rather than relying on a shared peptide category.
Each vial contains 10 mg of Pinealon. Select one vial for 10 mg total content, two vials for 20 mg, or three vials for 30 mg.
The 10 mg strength describes every individual vial. The pack choice changes the number of separately supplied vials, not the content of a single vial.
Synthetic tripeptide with the sequence Glu-Asp-Arg (EDR).
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.43% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.
Pinealon is the synthetic EDR tripeptide, with the sequence Glu-Asp-Arg.
